XSHE
300957
Market cap1.92bUSD
Jul 10, Last price
31.70CNY
1D
2.42%
1Q
-15.60%
IPO
-81.99%
Name
Yunnan Botanee Bio-Technology Group Co Ltd
Chart & Performance
P/E
26.41
P/S
2.49
EPS
1.20
Div Yield, %
1.94%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
15.24%
Revenues
5.36b
-6.58%
Net income
506m
+0.53%
CFO
977m
+40.54%
Dividend
May 30, 20250.6 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Yunnan Botanee Bio-Technology Group Co.LTD operates within the Chinese market, specializing in the development and distribution of a broad spectrum of skincare formulations. Its comprehensive product line encompasses cleansing and makeup removal solutions, facial masks, toners, serums, hydrating moisturizers, eye creams, refreshing facial sprays, sun protection items, cosmetic foundations, and general body care products. This enterprise, founded in 2010, is strategically headquartered in Kunming, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||